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Inflammatory cytokines play important roles in a variety of pathophysiological 
changes associated with traumatic injury and demyelinating disorders in the peripheral 
nervous system. After sciatic nerve injury, proinflammatory cytokines such as interleukin 
1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNFα) are produced by and 
act on neurons, Schwann cells, and infiltrating inflammatory cells at the lesion site. 
Underlying these processes is receptor-mediated activation of intracellular signaling 
pathways that regulate cell differentiation and proliferation and synthesis of axon and 
myelin components. This review focuses on roles of inflammatory cytokines in the 
degeneration and regeneration of the peripheral nerve. In addition, we describe here 
altered expression of inflammatory cytokines in gradually elongated rat sciatic nerves. 
This experimental model, which is devoid of Wallerian degeneration, provides insights 
into the involvement of inflammatory cytokines in the maintenance of myelinated axons. 
Based on the findings obtained from nerve elongation models and those from 
conventional nerve injury models, we discuss the molecular mechanism that ensures the 





Inflammatory cytokines are small secreted proteins that modulate inflammatory and 
immune responses (Dinarello, 2000; Borish & Steinke, 2003). A group of inflammatory 
cytokines is composed of members belonging to distinct cytokine families including TNF-, 
IL-1-, IL-6-, interferon (IFN)-, and transforming growth factor (TGF)-families (Tracy & 
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Cerami, 1993; Dinarello, 2009; Hirano et al., 1997; Borden, et al., 2007; Derynck & 
Miyazono, 2008). Based on their activities, inflammatory cytokines are divided into two 
types: proinflammatory cytokines, such as TNFα, IL-1, IL-6, IL-12, and IFNγ; and anti-
inflammatory ones, such as IL-4, IL-10, IL-13, and TGFβ (Dinarello, 2000; Borish & Steinke, 
2003; Shubayev, et al., 2010). Depending on conditions, however, certain proinflammatory 
cytokines can be anti-inflammatory, and vice versa. Proinflammatory cytokines initiate and 
promote inflammation by mobilizing and attracting leukocytes, whereas anti-inflammatory 
cytokines inhibit or terminate inflammation by antagonizing the effects of proinflammatory 
cytokines. 
In the peripheral nervous system (PNS), as well as in the central nervous system (CNS), 
inflammation is a prerequisite process for degeneration and subsequent regeneration. 
Although earlier cytokine research was conducted mainly in circulating leukocytes and 
lymphatic tissues, accumulating evidence has established that they contribute to normal 
development and pathologic conditions associated with traumatic injury and 
inflammatory/immune demyelinating neuropathies (Créange et al., 1997; Skundric & Lisak, 
2003; Pletz et al., 2003; Leinninger et al., 2004; Martini et al., 2008). Previous studies have 
shown that inflammatory cytokines are produced not only by infiltrating hematogenous 
leukocytes but also by neurons, Schwann cells, and resident macrophages. These cells are 
also known to express various cytokine receptors (Hirota et al., 1996; Grothe et al., 2000; 
George et al., 2005; Lara-Ramírz t al., 2008; Ozaki t al., 2008) and downstream signaling 
molecules (Sheu et al., 2000; Zrouri et al., 2004; Girolami et al., 2009; Wang et al., 2009) In 
concert with neurotrophins, chemokines, and other neurotrophic factors, inflammatory 
cytokines form an intricate network, thereby participating in the initiation, progression, and 
termination of many cellular responses including neuronal survival and death, axonal 
degeneration, loss, regrowth, and remyelination of axons by Schwann cells (Créange et al., 
1997; Boyd & Gordon, 2003; Chen et al., 2007; Navaro et al., 2007). 
This chapter reviews pathophysiological roles of inflammatory cytokines in the 
degeneration and regeneration of the peripheral nerve and describes their possible 
involvement in cellular processes in non-degenerative peripheral nerves. 
 
 




There are two structurally distinct receptors for TNF: TNFR1 (also known as p55) and 
TNFR2 (also known as p75) (Shuvayev et al., 2010). The cytoplasmic domains of these 
receptors recruit different proteins that transduce downstream signaling. In one case, the 
TNFR1 cytoplasmic domain is linked to cell death pathways, but this is not the case with 
TNFR2. Both receptors, however, lead to the translocation of the nuclear factor-κB (NF-κB), 
a key transcription factor, into the nucleus. Then NF-κB binds to the promoter regions of 
diverse genes. TNFR1 has a cell death-related domain and recruits a protein called MORT-1 
and other intracellular proteins, referred to as TNFR-associated factors. The TNFR1 
cytoplasmic domains also recruit the family of proteins called TNFR-associated death 
domains (TRADDs). The overexpression of TRADDs evokes cell death and activates NF-κB. 
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In addition, TRADDs activate the caspase family of intracellular cysteine proteases, some of 





Two distinct binding proteins (IL-1 receptors: IL-1Rs) and one IL-1R accessory protein 
(IL-1R-AcP) have been identified. The extracellular domains of the two IL-1Rs and the IL-
1R-AcP share a common structural feature. Binding of IL-1 to its receptor induces several 
transcription factors. In most instances, induction of IL-1-related genes is dependent on 
nuclear translocation of NF-κB and another nuclear factor AP-1. TNF- and IL-1-related 
cytokines activate NF-κB and RAS/mitogen-activated kinase (RAS/MAPK) pathways 





The IL-6-family of cytokines share a common receptor subunit designated gp130 
(Ishihara & Hirano, 2002; Ernst & Jenkins, 2004). Through binding to their specific receptors 
in many tissues, these cytokines activate intracellular signaling cascades and alter gene 
expression levels in target cells. Many ILs and IFNs activate Janus kinase-signal transducers 
and activators of transcription (JAK/STAT) pathway (Heinrich et al., 2003; Dziennis & 
Alkayed, 2008). 
One important aspect is that some receptors are secreted as a soluble form (Levine, 2008). 
In general, soluble cytokine receptors are generated by proteolytic cleavage, by alternative 
splicing, or by expression of distinct genes that encode secreted cytokine-binding proteins 
(Levine, 2008). Importantly, these soluble receptors bind their target ligands and modulate 
their activity in either an antagonistic or agonistic fashion (Levine, 2008). 
 
 
3. EFFECTS ON DEGENERATIION AND REGENERATION OF 
PERIPHERAL NERVE 
 
Traumatic injury, toxicity, autoimmune, and metabolic damages elicit a sequence of 
cellular responses including neuronal cell death or survival, axonal degeneration, axonal 
regrowth, dedifferentiation and proliferation of Schwann cells, and remyelination (Waller, 
1850; Fawcett & Keynes, 1990; Ide, 1996; Fu & Gordon, 1997; Hall, 2005; Makwana & 
Raivich, 2005; Raivich & Makwana, 2007). During these responses, various inflammatory 
cytokines exhibit upregulated expression in many types of cells, such as motor and sensory 
neurons, Schwann cells, resident and infiltrating macrophages, lymphocytes, mast cells, and 
fibroblasts (Okamoto et al., 2001; Stoll, et al., 2002). Proinflammatory cytokines, such as IL-
1β, IL-6, and TNFα, are produced by and act on neurons, Schwann cells, and infiltrating 
inflammatory cells in autocrine and paracrine manners, forming an intricate network with 
other factors. 
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Responses in the Nerve Cell Body 
 
After nerve injury, a proportion of motor neurons in the spinal cord and primary sensory 
neurons in dorsal root ganglia (DRG) undergo cell death, and surviving cells exhibit changes 
to promote regeneration at both the cellular and molecular levels (Lieberman, 1974; 
Richardson et al., 2009). Several distinct pathways convey signals from injured sites to cell 
bodies (Snider et al., 2002; Abe & Cavalli, 2008). At the lesion site, Schwann cells produce 
LIF and CNTF, both of which belong to the IL-6 family and activate the gp130/JAK/STAT 
signaling. The resulting phosphorylated form of STAT3 (pSTAT3) is then transported 
retrogradely into the nucleus and upregulates the transcription of axonal regeneraton-related 
genes (Lee et al., 2004). This process is facilitated by a broad spectrum of trophic factors 
secreted by many types of cells. Such factors include neurotrophins, neuropoietic cytokines, 
insulin-like growth factors (IGFs), and glial cell line-derived neurotrophic factors (GDNFs).  
Upon injury, IL-6 is induced in neurona cell bodies (Kiefer et al., 1993; Murphy et al., 
1995; Hirota et al., 1996; Osamura et al., 2005) as well as in Schwann cells (Bolin et al., 
1995). IL-6 is a well-known pleiotrophic cytokine that is involved in neuronal survival 
(Gadient and Otten, 1997; Hirano et al., 1997; Heinrich et al., 1998). IL-6 further induces the 
expression of various genes associated with degeneration and regeneration (Lee et al., 2009a 
& b). Transgenic mice expressing both IL-6 and IL-6 receptor (IL-6R) showed accelerated 
regeneration of axotomized hypoglossal nerve (Hirota et al., 1996). In IL-6 knockout mice, its 
functional recovery was delayed after the crush lesion of the sciatic nerve (Zhong et al., 1999). 
When the sciatic nerve was transected, retrograde death of L5 DRG neurons was 45% greater 
in IL-6 knockout mice than in wild-type ones (Murphy et al., 1999). In addition, exogenously 
applied human IL-6 and soluble human IL-6R promoted the survival of DRG neurons 
cultured from newborn rats (Thier et al., 1999). IL-6 is thus thought to moderate the death of 
neurons that undergo Wallerian degeneration. Other factors including IL-1β also have 
protective effects on neurons (Ikeda et al., 1996; Carlson et al., 1999; Diem et al., 2003)  
 
 
Axonal Degeneration and Phagocytosis 
 
In degenerated peripheral nerve, both resident endoneural and infiltrating blood-derived 
macrophages serve as scavengers of myelin debris. Upon peripheral nerve injury, Schwann 
cells rapidly and transiently synthesize TNFα, which initiates the cytokine network and 
recruits macrophages from the blood circulation (Wagner & Myers, 1996; Oka et al., 1998; 
Liefner et al., 2000; Kiefer et al., 2001; Leonhard et al., 2002; Mueller et al., 2003; Mäurer et 
al., 2003; Siebert & Brück, 2003; George et al., 2004; Cheepudomwit et al., 2008). The 
activated macrophages at injured and demyelinated sites further produce TNFα and 
phagocytose myelin, resulting in Wallerian degeneration (Stoll, et al., 1993). TNFα has been 
shown to induce inflammatory demyelination and Wallerian degeneration by activating the 
transcription of genes in Schwann cells (Bonetti et al., 2000). In TNFα-deficient mice, 
macrophage recruitment into transected, degenerating sciatic nerve, and clearance of myelin 
debris was delayed, without significant loss of phagocytotic activity (Liefer et al., 2000). This 
observation indicates that the major role of TNFα is recruitment of macrophage from 
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peripheral blood into the injury site. The production of TNFα is suppressed by IL-10 (Wagner 
et al., 1998) and erythropoietin (Li et al., 2005; Campana et al., 2006). 
IL-1α, IL-1β, ICE, and type 1 IL-1 receptor (IL-1RI) are constitutively expressed in a 
normal adult sciatic nerve. Upon injury, IL-1 is locally produced by Schwann cells, 
endoneural and infiltrating macrophages and fibroblasts in the peripheral nerve, and dorsal 
root ganglion (DRG) neurons (Lisak et al., 1997). IL-1 promotes phagocytosis by 
macrophages and the synthesis of other factors, such as nerve growth factor (NGF), leukemia 
inhibitory factor (LIF), and macrophage chemoattractant protein-1 (MCP-1), by Schwann 
cells and sensory neurons (Lindholm et al., 1987; Rotshenker et al., 1992; Shadiac et al., 
1993; Carlson et al., 1996; Basu et al., 2004; Perrin et al., 2005). Schwann cells of denervated 
nerves attract macrophages by secretion of MCP-1 in a process regulated by IL-6 and LIF 
(Tofaris et al., 2002). 
 
 
Regrowth of Axons 
 
In injured nerve, neuropoietic cytokines, including IL-1β, IL-6, LIF, and TGF-β1, are 
upregulatedly expressed and promote axonal growth. Sprouted axons then establish the 
contact with Schwann cells. During this period, axotomized neurons transit from a 
transmitting mode to a growth mode, and produce growth-associated proteins, such as GAP-
43, tubulin, and actin, as well as diverse neuropeptides and cytokines that promote axonal 
regeneration. Macrophages also can produce neurite-promotoing factors (Luk et al., 2003). 
IL-1β promotes axonal growth of sensory neurons (Horie et al., 1997; Temporin et al., 2008a), 
by deactivating RhoA through the p38 MAP kianse pathway (Horie et al., 1997; Temporin et 
al., 2008b). Inhibition of TNFα-activeted p38 MAP kinase enhances the axonal regeneration 
(Myers et al., 2003). In organotyoic mouse DRG explants, IL-4 increased outgrowth induced 
by neurotrophin-4 (NT-4); IL-6 stimulated outgrowth by neurotrophin-3 (NT-3) and NT-4; 
and IFNγ stimulated neurite extension in the presence of NT-3 plus NT-4 and NT-3 plus NGF 
(Gölz et al., 2006). In contrast, TNFα inhibited outgrowth induced by NT-3, NT-3 and/or plus 
NGF (Gölz et al., 2006). TNFα has been also reported to inhibit the neurite outgrowth of 
DRG explants through down-regulation of myelin associated glycoprotein (Schneider-
Schaulies et al., 1991). However, TNFα supposedly induces sensory nerve growth, possibly 
leading to pain (Hayashi et al., 2008), although part of this action might be mediated by the 
stimulatory effect of TNFα on the production of NGF (Hattori et al., 1993). 
 
 
Dedifferentiation and Proliferation of Schwann Cells 
 
In both normal development and pathologic states, Schwann cells provide trophic support 
for peripheral neurons by producing inflammatory cytokines, as well as neurotrophins and 
other cytokines (Bhatheja & Field, 2006; Lisak & Benjamins, 2007; Mirsky et al., 2008; 
Madduri & Gander, 2010). After axonal degeneration, Schwann cells dedifferentiate and 
proliferate (Livesey et al., 1997). Conti et al. (2002) have shown that IL-1 promotes 
proliferation and apoptosis in cultured Schwann cells. Subsequently, as degenerated axons 
start regrowing, Schwan cells quit dividing and start myelination. Schwann cells in the distal 
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stump undergo proliferation and phenotypical changes to prepare the local environment to be 
favorable for axonal regeneration. In addition to producing many neurotrophic factors and 
their receptors, Schwann cells produce cell-surface adhesion molecules, which serve as 
components of the basement membrane, along with many extracellular matrix proteins, such 





Schwann cells are responsible for myelination and ensheathment of myelinated axons and 
synthesis of myelin components (Garbay et al., 2000; Jessen & Mirsky, 2005; Chen et al., 
2007; Svaren & Meijer, 2008). It is well known that myelination is regulated by various 
endogenous modulators including extracellular matrix proteins, neurotrophins, and cytokines 
(Boyd & Gordon, 2003; Notterpek, 2003; Rosenberg, et al., 2006; Chen, et al., 2007). Of 
these, the IL-6 family of cytokines, such as ciliary neurotrophic factor (CNTF), LIF, and IL-
11, are thought to have substantial importance, because mice genetically depleted of the 
gp130, a common receptor subunit for these cytokines, undergo degeneration of peripheral 
myelin sheath (Betz et al., 1998).  
IL-6 is involved in various pathophysiological processes in the PNS. Several studies have 
demonstrated that the expression of IL-6 and IL-6 receptor α subunit (IL-6Rα) is upregulated 
in dorsal root ganglion (DRG) neurons after axonal injury and elongation (Lara-Ramiréz et al., 
2008). IL-6 is also known to promote myelination of Schwann cells. In cultured mouse and 
rat embryonic DRG, IL-6 fused to soluble IL-6 IL-6R stimulated the expression of many 
genes for myelin-associated proteins including P0 and myelin basic protein (MBP) (Haggiag 
et al., 1999; Zhang et al., 2007). Intraperitoneal injection of IL-6 along with IL-6R increased 
4-fold the number of myelinated axons and thickness of myelin sheaths following suture of 
transected rat sciatic nerves (Haggiag et al., 2001). Subcutaneous injection of IL-6 prevented 
cisplatin-induced degeneration of rat sciatic nerve (Callizot et al., 2008) and improved 
reduced nerve conduction velocity of the sciatic nerve of streptozotocin-induced diabetic rats 
(Cotter et al., 2010).  
As already established in non-neuronal tissues, these cytokines exert their effects through 
the JAK/STAT and RAS/MAPK pathways (Ishihara & Hirano, 2002; Ernst & Jenkins, 2004). 
The balance or interplay of these pathways is thought to determine the cell type-specific 
responses. Although receptor subunits specific for these cytokines and gp130 are expressed in 
Schwann cells, very little is known about their downstream effector molecules. 
In a study using cultured rat Schwann cells, we demonstrated that IL-6 elevated the 
mRNA level of PMP22 but not those of MPZ and MBP, and that the increase in PMP22 
mRNA is and accompanied by phosphorylation of JAK2 and STAT3 (Ito et al., 2010). The 
increase in PMP22 mRNA was JAK2 inhibitor-sensitive, but MAPK kinase-insensitive (Ito et 
al., 2010). PMP22 is a tetraspan glycoprotein vigorously produced by myelinating Schwann 
cells. Despite its abundant presence in the compact myelin, the physiological role of PMP22 
has not been fully clarified. In good correlation with myelin formation, PMP22 expression in 
the sciatic nerve is strongly upregulated during the postnatal period and during nerve 
regeneration after injury. Duplication of the PMP22 genes is associated with hereditary 
demyelinating neuropathies, such as Charcot-Marie-Tooth disease type 1A, and deletion of a 
single gene copy leads to hereditary neuropathy with liability to pressure palsies. Amici et al. 
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(2006) showed that PMP22 forms a complex with α6β4 integrin and laminin, suggesting its 
involvement in the interaction between Schwann cells and the surrounding basal lamina. 
Therefore, together with the observation that conditional knockout of the mouse gp130 gene 
caused degeneration of myelin sheath, we surmise that IL-6-signaling through the 
gp130/JAK/STAT pathway may regulate PMP22 expression and thereby contribute to the 
formation or stabilization of the compact myelin. 
Earlier studies have revealed that PMP22 expression is regulated transcriptionally by 
cyclic AMP and post-transcriptionally by microRNA-29a (Verrier et al., 2009). The 
relationship between these regulatory processes and the present results is currently unclear. In 
DRG neurons, levels of IL-6 mRNA and IL-6 increase rapidly within a day and gradually 
decrease over a period of 1–2 weeks after transection and elongation of the sciatic nerve 
(Gadient et al., 1997; Osamura et al., 2005). Also, Sheu et al. (2000) have shown that 
phosphorylation of STAT3, in both proximal and distal ends, peaks within a day but remains 
for more than 2 weeks (See also Fig.1). In contrast, the PMP22 mRNA level declines 
immediately after nerve injury and then is upregulated after 1 week (Snipes et al., 1992). 
Conceivably, the IL-6-signaling through the gp130/JAK/STAT pathway may participate in 
the delayed upregulation of PMP22; however, the initial reduction could not be explained by 
the same mechanism. More detailed analysis is required to determine the contribution of the 
IL-6 and gp130/JAK/STAT signaling to the peripheral nerve regeneration. If this pathway is 
critical for in vivo myelin synthesis, the recent challenges for pharmacological interventions 
targeting the gp130-mediated signaling (Fischer et al., 2008) might benefit the treatment of 
neuropathies associated with abnormal myelin formation. Also, upon Schwann cell 
transplantation into injured neural tissues (Kocsis & Waxman, 2007; Woodhoo et al., 2007), 




Figure 1. Immunoperoxidase staining for phosphrylated STAT3 (pSTAT3) and STAT3. At 1 day after 
transection of the left sciatic nerve, proximal (Prox) and distal (Dist) nerve stumps, and contralateral 
(Contra) were subjected to staining with anti- pSTAT3 and anti-STAT3 antidodies. In the proximal 
stump, intense immunoreactivity (IR) for pSTAT3 is detectable in cells located along axons. Scale bar, 
20 μm. 
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In addition to its degenerative action, TNFα has also been reported to aid regeneration by 
protecting injured neurons (Cheng et al., 1994) or by up-regulating synthesis of myelin-
specific proteins, such as myelin basic protein (Huang et al., 2002). For all these findings, 
elucidation of regulatory mechanisms for peripheral myelination is still in its infancy; there 




4. POSSIBLE ROLES IN PRE- OR NON-DEGENERATIVE  
PERIPHERAL NERVE 
 
Most experiments using peripheral nerves, especially the sciatic nerve, have been 
conducted toward the elucidation of degeneration, regeneration, and pain. Besides, 
inflammatory cytokines play roles in pre- or non-degenerative myelinated fibers, although the 
number of reports is limited. This section reviews the alterations observed in gradually 
elongated sciatic nerves and those in contralateral sciatic nerves after unilateral sciatic nerve 
elongation and injury. 
 
 
Gradual Sciatic Nerve Elongation 
 
Gradual nerve elongation was originally developed for the reconstruction of segmental 
nerve defects in peripheral nerve surgery. Although transplantation of autologous nerve grafts 
has been a standard operation, the outcome is not always satisfactory due to sensory deficit in 
the donor site, the limited length of donor nerves, and the requirement for axonal regeneration 
across two anastomotic sites (Doi et al., 1993, Orbay et al., 1993; Taylor, 1976). These 
problems are inevitable in most instances, and thus, alternative procedures are awaited. 
Recently, several studies have demonstrated that gradual nerve elongation can achieve results 
comparable to nerve grafting not only in experimental animals (De Bastiani et al., 1987; 
Orbay et al., 1993; Ohkaya et al., 2000; Kroeber et al., 2001; Jiang et al., 2004; Matsuzaki et 
al., 2004), but also in clinical applications (Manders et al., 1987). This procedure has 
advantages over nerve grafting, as a defect can be bridged by an elongated nerve without 
donor-site problems and anastomosed at one site. Besides these studies in vivo, nerve 
elongation can be applied to producing transplant materials in vitro (Pfister et al., 2004). 
More importantly, in contrast with conventional sciatic nerve injury models, the gradual 
elongation model is devoid of Wallerian degeneration. During successful elongation, the 
peripheral nerve exhibits an adaptative response, in which stretched axons escape 
degeneration and retain electrical impulse conduction. Previous studies have shown that 
axonal degeneration occurs in acutely elongated nerves, but not in gradually elongated nerves 
(Galardi et al., 1990; Polo et al., 1997; Ikeda et al., 2000; Abe et al., 2004). Gradual 
elongation at a rate within 1 mm/day does not interrupt nerve conduction (Skoulis et al., 
1998; Ikeda et al., 2000; Yokota et al., 2003). Gradual elongation at the rate of 2 mm/day 
causes neither axonal transport insufficiency nor destruction of the blood–nerve barrier 
function (Ikeda et al., 2001). This is also the case with the current rat model (Osamura et al., 
2007). Upon elongation, individual Schwann cells cover a lengthened internode by cell body 
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extension, rather than by cell proliferation (Abe et al., 2002; Yokota et al., 2003). Providing 
that myelin components are supplemented to elongated myelin sheaths, cytokines and 




Figure 2. RT-PCR analysis for various cytokines and neurotrophins. Total RNA was obtained from L4–
6 DRG of the 2-mm/day group 1 day after sciatic nerve elongation (top), untreated control (middle), 
and positive control (bottom). After reverse transcription, cDNA was subjected to amplification with 
specific primers for the indicated factors. Note that IL-1β and IL-6 mRNA are detected only in the 
nerve elongation model. (Reproduced with permission from Osamura et al., 2005. Copyright 2005 
Elsevier Ltd.) 
In our study, the expression of IL-6 was prominently induced in DRG neurons after 
gradual elongation of rat sciatic nerves (Fig. 2). The induction was detected not only in the 
acutely elongated 20-mm/day group, in which nuclear eccentricity in the cell body and 
degenerated axons were observed, but also in the gradually elongated 1- and 2-mm/day 
groups, in which no degenerative change was detectable. These data indicate that peripheral 
sensory neurons perceptively react to axonal elongation by producing IL-6. Although NGF, 
BDNF, and NT-3 are known to be involved in the process of myelination (Mattson, 2003; 
Notterpek, 2003), mRNAs for these factors did not show any change in the DRG of the 
gradually elongated models (Fig. 2). The selective induction of IL-6 may provide a molecular 
explanation for the adaptation of gradually elongated 1- and 2-mm/day groups. In the 20-
mm/day group, in which a fraction of fibers are degenerated, the neuroprotective action of IL-
6, as described in the transected sciatic nerve, may be effective. 
In addition, we have also demonstrated in this study that IL-6 can stimulate the 
expression of mRNA for PMP22, a major myelin component that exhibits expression changes 
similar to myelin protein zero (MPZ) during normal development and after peripheral nerve 
injury (Welcher et al., 1991; Kuhn et al., 1993; Notterpek et al., 1999; Suter, 2004). Together 
with the observation that the expression of P0 gene is up-regulated by gradual elongation of 
rat sciatic nerves (Hara et al., 2003), it is conceivable that IL-6, at least in part, mediates the 
expression of genes for myelin-specific proteins in gradually elongated nerves. The resulting 
proteins may be supplied to the Schwann cell body lengthened by the nerve elongation 
procedure. 
Occasionally, the adaptation is preceded by minimal damage around the node of Ranvier. 
When a rabbit sciatic nerve was elongated at the rate of 2 mm/day, the myelin sheath in the 
paranodal region was straightened and nodes of Ranvier became wider, resulting in reversible 
partial conduction block (Ikeda et al., 2000). Yokota et al. (2003) also reported similar 
Shigeru Yokoyama 10 
changes in teased myelinated fibers. We assume that IL-6 is also involved in repairing 
extended paranodal myelin sheath. Murphy et al. (1999) suggested that, in axotomized DRG 
neurons, the induction of IL-6 mRNA is initiated by a factor released from mast cells at the 
injury site. In contrast with the strong and relatively brief induction in the axotomized group, 
the 1- and 2-mm/day groups exhibited a more sustained induction, keeping much lower 
mRNA levels. The difference might reside in whether or not Wallerian degeneration occurred. 
IL-6 induction in the acutely elongated 20-mm/day group, which was accompanied by 
Wallerian regeneration, appears to have both characteristics. We consider that DRG neurons 
employ two distinct mechanisms for IL-6 induction: an axonal-injury-dependent one as 
described by Murphy et al. (1999) and an axonal-elongation-dependent one that is free from 
degeneration. 
In another study, we demonstrated that the expression of TNFα mRNA is induced in rat 
sciatic nerves after gradual elongation, whereas mRNAs for IL-1β, IL-6, NGF, BDNF, NT-3 
and NT-4/5 remain undetectable (Fig. 4). Our data indicate that TNFα is produced by non-
proliferating Schwann cells. In contrast with transaction and acute elongation of the sciatic 
nerve, gradually elongated nerves lacked in a prominent rise in TNFα mRNA immediately 
after 20-mm lengthening. Moreover, as shown in the histochemical staining, most TNFα-
producing cells in gradually elongated nerves are not macrophages, but Schwann cells in the 
non-proliferative state. These histological findings sharply contrast with those in Wallerian 
degeneration after usual injury. Hence, it is unlikely that TNFα produced in gradually 
elongated nerves mediates degenerative responses as in injured nerves. It is rather 
conceivable that TNFα acts as a mediator of regenerative responses. As already mentioned 
above, IL-1β, IL-6, TNFα, NGF, brain-derived neurotrophic factor (BDNF), neurotrophin-3 
(NT-3), and neurotrophin-4/5 (NT-4/5), are involved not only in neuronal survival and neurite 
outgrowth (Hattori et al., 1993; Boyd & Gordon, 2003), but also in myelin formation by 
Schwann cells (Chan et al., 2001; Cosgaya et al., 2002). We surmise that TNFα acts on 
Schwann cells in a paracrine or autocrine manner, stimulates myelin synthesis necessary for 
insulation of lengthened internodes, and thereby facilitates the adaptation of peripheral nerve 
to gradual elongation. In the acute elongation model, the expression of TNFα mRNA is 
probably influenced by both injury and elongation. Provided that expression glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) mRNA was unchanged by elongation, the level of 
TNFα mRNA in the 20-mm/d group was significantly higher than those in the 1- and 2-mm/d 
groups. One possibility is that damages in surrounding tissues contribute to the marked 
increase in TNFα mRNA at day 1, as described in transected sciatic nerves (Wagner et al., 
1996; Oka et al., 1998; Liefner et al., 2000; Taskinen et al., 2000; Shamash et al., 2002; 
Siebert et al., 2003; George et al., 2004). At 1 day after acute 20-mm elongation, TNFα might 
play a role in inflammatory degenerative processes. In summary, peripheral sensory neurons 
sense gradual nerve elongation and produce IL-6, which may serve as an active signal in the 
process of the adaptation of its length. Also, gradual nerve elongation by limb lengthening 
elicits production of TNFα by Schwann cells. In addition to the well-studied degenerative 
actions in Wallerian degeneration, TNFα could play a critical role in the adaptative response 
in elongated peripheral nerves. These results provide a molecular basis for peripheral nerve 
elongation as a treatment for a segmental peripheral nerve defect. Further studies would 
clarify whether controlling TNFα action could reduce nerve damage after elongation and 
ameliorate the complications of limb lengthening. 
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Contralateral Effects — Transmedian Signaling 
 
Following unilateral sciatic nerve injury, the expression of inflammatory cytokines is 
often increased in the contralateral non-lesioned side (Koltzenburg er al., 1999). The 
magnitude of this transmedian effect is smaller, and duration is shorter.  
We observed that, after injury to the left sciatic nerve, the expression of IL-6 mRNA was 
upregulated in the right DRG, although the extent was less than that in the ipsilateral side 
(Figs. 3 & 5; Osamura et al., 2005). Transection of unilateral sciatic nerve accelerated the 
neurite outgrowth of neurons cultured from the contralateral DRG (Yamaguchi et al., 1999). 
Ryoke et al. (2000) demonstrated that sciatic nerve transection enhanced the expression of IL-
1β and TGF-β in the contralateral DRG neurons, and promoted regeneration of the 
contralateral nerve. Also, Ruohonen et al. (2002) reported that sciatic axotomy significantly 
raised the expression levels of IL-1β, TGF-β1, TNFα, and IL-10 in uninjured contralateral 
sciatic nerves. These phenomena appear to share some common features with the 
conditioning lesion that enhances ipsilateral nerve regeneration capacity (McQuarrie & 
Grafstein, 1973; Smith & Skene, 1997). 
 
Figure 3. Expression levels of IL-6 mRNA in DRG 1 day after sciatic nerve elongation and transection. 
Total RNA was extracted from ipsilateral and contralateral L4-6 DRG, and subjected to RT-PCR 
followed by Southern blot hybridization analysis. A bar graph represents densitmetrically analyzed 
band intensities for IL-6. Representative autoradiograms for IL-6 and GAPDH are given. Intensities for 
IL-6 were normalized to those for GAPDH. Note that IL-6 mRNA is also induced in the contralateral 
side of the 1- and 2-mm/d groups. In the 20-mm/d and axotomized groups, levels of IL-6 mRNA are 
significantly high compared with the 1- and 2-mm/d groups. Data show mean ± SEM obtained from 5 
independent experiments. Fisher’s post-hoc t-test was used to compare IL-6 mRNA level of each group 
1 day after lengthening or transection (* P < 0.05; ** P < 0.01). (Reproduced with permission from 
Osamura et al., 2005. Copyright 2005 Elsevier Ltd.) 
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More recently, IL-6 has been shown to be necessary or sufficient for conditioning-injury-
induced regeneration of dorsal column axons (Cafferty et al., 2004; Cao et al., 2006). Given 
the regenerating activity of IL-6, it is tempting to postulate that gradual nerve elongation, like 
conditioning lesion, may increase the nerve regenerating capacity or stimulate the 
myelination of Schwann cells on the opposite side. Also, this phenomenon might have 
clinical importance. For example, in a case that requires nerve elongation in bilateral 
extremities, IL-6 could be a useful indicator in deciding the appropriate timing for surgery at 
the contralateral side following the initial elongation. 
We also detected the increasing of TNFα mRNA in contralateral sciatic nerves that had 
not been elongated (Figs. 4 & 5; Hagiwara et al., 2005). The induction of TNFα mRNA was 
not detected in ipsilateral L4-6 dorsal root ganglia of the same gradual elongation model 
(Osamura et al., 2005). Although the precise role of TNFα in this phenomenon is currently 
unclear, our data raise the possibility that gradual elongation, like axotomy, might enhance 
the regenerating capacity of peripheral nerves. In the chronic constriction injury model, 
mRNA levels for IL-1β, IL-10 and MCP-1, but not for TNF-α, were elevated in the 
contralateral side (Kleinschnitz et al. 2005). This upregulation was inhibited by MK-801, an 
N-methyl-D-aspartate (NMDA) receptor antagonist, indicating the involvement of 




Figure 4. Expression levels of TNFα mRNA in sciatic nerves 1 day after 20-mm lengthening. Total 
RNA extracted from ipsilateral and contralateral sciatic nerves was processed for RT-PCR followed by 
Southern blot hybridization analysis. A bar graph represents densitometrically analyzed band intensities 
for TNFα. The intensities were normalized to those for GAPDH. Given are representative 
autoradiograms for TNFα and GAPDH. Data show mean ± SEM obtained from 4 independent 
experiments. Fisher’s post-hoc t-test was used to compare TNFα mRNA level of each group 1 day after 
lengthening (* P < 0.05; ** P < 0.01; NS, not significant). (Reproduced with permission from Hagiwara 
et al., 2005. Copyright 2005 Japanese Orthopaedic Association) 
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Figure 5. Schematic representation of contralateral effects. Expression of mRNA for IL-6 and TNF-α 
are depicted based on our previous studies (Osamura et al., 2005; Hagiwara et al., 2005). IL-6 mRNA 
in DRG and TNF-α mRNA in sciatic trunk are increased in both ipsilateral and contralateral side, 
although the contralateral elevation is less in magnitude.  
At present, little is known about the underlying signaling mechanism that connects the 
left and right sides of the PNS. There are two putative peripheral mechanisms by which 
contralateral change might occur: (i) Contralateral effects mediated by circulating factors and 
(ii) those by transmedian sprouting (Koltzenburg et al., 1999). In the former hypothesis, 
breakdown products from the damaged nerve or denervated tissue are thought to circulate via 
the bloodstream and induce changes in contralateral neuronal populations. In the latter 
hypothesis, unilateral nerve lesions promote collateral, transmedian sprouting of neurons in 
peripheral tissues that receive bilateral inputs. Such collateral sprouting across the midline 
might cause other changes in these contralateral neurons. Koltzenburg et al. (1999) have also 
proposed central mechanisms whereby the contralateral effects are mediated by dendrites of 
motor neurons, central termini of primary sensory neurons, or spinal interneurons. 
The pathophysiological significance of the contra-lateral effect is also largely unknown. 
This transmedian signaling could account for bilateral loss of distal skin innervation after 
unilateral injury (Oaklander & Brown, 2004) and mirror-image pain that arises in a 





Extensive studies over decades have revealed that inflammatory cytokines exert multiple 
effects on many types of cells in degenerating and regenerating peripheral nerves. Some 
effects are beneficial and others detrimental, for precise renervation of target organs and 
restoration of nerve conductivity. With the recent advances in the development of 
pharmacological interventions, such as neutralizing monoclonal antibodies and receptor 
antagonist (Kato et al., 2009; Kato et al., 2010), it will be easier to optimize cytokine effects 
toward accelerated and controlled functional recovery from traumatic injury and 
demyelinating neuropathies.  
In addition to the well-known pathologic states, recent studies have suggested that 
inflammatory cytokines may play roles in pre- or non-degenerative nerves. In the future, more 
effort should be directed toward clarifying the molecular mechanisms and pathophysiological 
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